D.R. Horton
DHI
Lennar Corp
LEN
KB Home
KBH
Petroleo Brasileiro SA Petrobras
PBR
Ecopetrol
EC
US Stock MarketDetailed Quotes
AVXL Anavex Life Sciences
- 8.990
- +0.320+3.69%
Close Mar 10 16:00 ET
- 8.980
- -0.010-0.11%
Post 19:55 ET
764.73MMarket Cap-16.35P/E (TTM)
9.248High8.410Low909.09KVolume8.460Open8.670Pre Close8.12MTurnover1.10%Turnover RatioLossP/E (Static)85.06MShares14.44152wk High6.89P/B741.45MFloat Cap3.25052wk Low--Dividend TTM82.47MShs Float31.500Historical High--Div YieldTTM9.66%Amplitude0.600Historical Low8.927Avg Price1Lot Size
About Anavex Life Sciences Company
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.
Company Profile
SymbolAVXL
Company NameAnavex Life Sciences
Listing DateOct 28, 2015
Founded2004
CEODr. Christopher U. Missling, PhD
MarketNASDAQ
Employees42
Fiscal Year Ends09-30
Address630 5th Avenue,20th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10111
Phone1-844-689-3939
Websitehttp://www.anavex.com
Company Executives
- Name
- Position
- Salary
- Dr. Christopher U. Missling, PhD
- Director, President, Chief Executive Officer and Secretary
- 3.89M
- Sandra Boenisch, C.G.A.,C.P.A.
- Principal Financial Officer, Principal Accounting Officer and Treasurer
- 501.06K
- Dr. Jiong Ma, PhD
- Chairman of the Board
- 349.54K
- Athanasios Skarpelos
- Independent Director
- 341.54K
- Dr. Steffen Thomas, PhD
- Independent Director
- 341.54K
- Dr. Peter Donhauser, D.O.
- Independent Director
- 341.54K
- Dr. Claus van der Velden, PhD
- Independent Director
- 357.54K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.